Read more
Australia’s GMP mirage: why ‘EU-GMP equivalent’ fails the global cannabis test
SOMAÍ chairman and interim CEO Michael Sassano says many Australian producers have work to do before they can compete on...
Read more
Thai flower in Australia: a tale of two contrasting worlds
It seems everyone is either queuing up to buy Thai flower or to invest directly in the country’s cultivation sector....
Read more
Pioneering Progress: How Italy’s Medical Cannabis Market is Evolving
Italy has long been one of the oldest European cannabis markets, which brought access to medical patients since 2015. Although...
Read more
SOMAÍ Continues Global Expansion with Launch in Italy Through Materia Medica Partnership
SOMAÍ, a leading EU-GMP vertically integrated Multi-Country Operator (MCO), continues its rapid expansion into key global markets with its official...
Read more
Cannabis Raids Across the Globe Sound a Call For Proper Regulation
From California to Portugal and Thailand, global cannabis raids reveal a persistent and dangerous illicit market—fueled by poor regulation, political...
Read more
Digital Access or Illicit Return? Restricting Telemedicine Could Drive 42% Back to Underground: Industry Insiders Weigh In
"As Germany debates cracking down on tele-clinics and flower sales, all eyes are on patient experience disruptions," Sassano said."Reversing course...
Read more
149_Michael Sassano, Master Multi-Country Operator
From Wall Street to Lisbon, from real estate to cannabis pharmaceuticals — Michael Sassano’s journey is anything but ordinary. In this...
Read more
Australia’s White-Label Identity Crisis: A Story of Quality, Branding and Margins
As the medical cannabis industry in Australia continues to boom with more patients than ever and the most modern products...
Read more
The New Era of Cannabis in Switzerland, Open Access and Education Lead B SOMAÍ and Dascoli Pharma Partnership
Switzerland has long been a country that wants to create a safe and sustainable future for its population — and...